Zoetis | ZTS - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 7.61B 2.04B 2026-06
Align Technology USD 148.69M 193K 2026-06
Bayer EUR 321M 2.67B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Coherus Biosciences USD -46.35M 90.86M 2025-12
Dentsply International USD -42M 105M 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
Henry Schein USD 137M 13M 2026-06
Idexx Laboratories USD 417.22M 61.78M 2026-06
Illumina USD 260M 103M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
J&J USD 8.66B 839M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Merck USD -3.53B 6.95B 2026-03
Neogen USD -20.3M 48.3M 2025-12
Pacira USD 5M 4.43M 2026-03
Perrigo USD 105.4M 513.9M 2026-06
Pfizer USD -653M 5.84B 2026-06
Phibro Animal Health USD 38.62M 1.26M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Sanofi EUR 837M 1.17B 2026-06
Sanofi EUR 2B 3.16B 2026-03
Zoetis USD 758M 3M 2026-03